Quick Win By The Algorithm: DVAX shows strong return and bright future

Quick Win By The Algorithm

On March 1, 2017 the I Know First algorithm had predicted a bullish forecast for Dynavax Technologies Corporation (DVAX). DVAX had a signal of 126.82 and a predictability of 0.15. Therefore, in accordance with the Quick Win By the Algorithm, the company reported gain of 38.89% in just 3 days.

Quick Win By The Algorithm

Dynavax Technologies Corporation (DVAX), a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the United States.

Dynavax Technologies Corp. stocks surged 54.4% after the company announced the Food and Drug administration would review its Hepatitis B vaccine. Additionally, the rise may also be due to comment made by President Trump during his Congressional address on Tuesday. He mentioned the FDA’s approval process was “slow and burdensome” and the restraints needed to be removed.

The FDA doesn’t look like they are rushing to approve another hepatitis B vaccine. Despite the documentation stating the need for a vaccine that is more effective for hard-to-treat populations like diabetes. The market looks set to continue to warm up to DVAX’s shares, as the vaccine’s estimated peak sales of around $700 million, sit at more double the current market cap of the company.

Finally, according to the analysts DVAX is a share in which you should continue to hold, as well as having a strong backing to buy.

This bullish forecast on DVAX was sent to current I Know First subscribers on March 1, 2017. 

Before making any trading decisions, consult the latest forecast as the algorithm constantly updates predictions daily. While the algorithm can be used for intra-day trading the predictability tends to become stronger with forecasts over longer time-horizons such as the 1-month, 3-month and 1-year forecasts.

Missed the latest trend? Looking for the next best market opportunity? Find out today’s stock forecast based on our advanced self-learning algorithm